{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:06:38Z","timestamp":1792782398544,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270668"],"award-info":[{"award-number":["82270668"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900586"],"award-info":[{"award-number":["81900586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274028"],"award-info":[{"award-number":["82274028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Heilongjiang Province of China","award":["JJ2024LH0246"],"award-info":[{"award-number":["JJ2024LH0246"]}]},{"DOI":"10.13039\/501100012593","name":"Scientific Research Foundation of Graduate School of Harbin Medical University: Sino Russian Special Fund","doi-asserted-by":"publisher","award":["2023-KYYWF-0164"],"award-info":[{"award-number":["2023-KYYWF-0164"]}],"id":[{"id":"10.13039\/501100012593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Foundation of the First Affiliated Hospital of Harbin Medical University","award":["2023 B11"],"award-info":[{"award-number":["2023 B11"]}],"id":[{"id":"https:\/\/ror.org\/05vy2sc54","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Postgraduate Research & Practice Innovation Program of Harbin Medical University","award":["YJSCX2023-64HYD"],"award-info":[{"award-number":["YJSCX2023-64HYD"]}],"id":[{"id":"https:\/\/ror.org\/05jscf583","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Science Fund for Distinguished Young Scholars of First Affiliated Hospital of Harbin Medical University","award":["HYD2020JQ0010"],"award-info":[{"award-number":["HYD2020JQ0010"]}],"id":[{"id":"https:\/\/ror.org\/05vy2sc54","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province","award":["CXPJJH11900018-2003"],"award-info":[{"award-number":["CXPJJH11900018-2003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06327-6","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T03:24:21Z","timestamp":1783308261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["UBE2L6 promotes invasion and metastasis of triple-negative breast cancer by enhancing autophagy through STK38 ISGylation"],"prefix":"10.1007","volume":"83","author":[{"given":"Liang","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Hui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Hao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Qi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Jie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-3709","authenticated-orcid":false,"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"8","key":"6327_CR1","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS et al (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22(8):1736\u20131747. https:\/\/doi.org\/10.1093\/annonc\/mdr304","journal-title":"Ann Oncol"},{"key":"6327_CR2","doi-asserted-by":"publisher","first-page":"215775","DOI":"10.1016\/j.canlet.2022.215775","volume":"547","author":"D Mehlich","year":"2022","unstructured":"Mehlich D, Marusiak AA (2022) Kinase inhibitors for precision therapy of triple-negative breast cancer: Progress, challenges, and new perspectives on targeting this heterogeneous disease. Cancer Lett 547:215775. https:\/\/doi.org\/10.1016\/j.canlet.2022.215775","journal-title":"Cancer Lett"},{"issue":"5","key":"6327_CR3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nrm3982","volume":"16","author":"A Ciechanover","year":"2015","unstructured":"Ciechanover A (2015) The unravelling of the ubiquitin system. Nat Rev Mol Cell Biol 16(5):322\u2013324. https:\/\/doi.org\/10.1038\/nrm3982","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"6327_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.molmed.2023.05.006","volume":"29","author":"D Han","year":"2023","unstructured":"Han D, Wang L, Jiang S et al (2023) The ubiquitin-proteasome system in breast cancer. Trends Mol Med 29(8):599\u2013621. https:\/\/doi.org\/10.1016\/j.molmed.2023.05.006","journal-title":"Trends Mol Med"},{"issue":"1","key":"6327_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K et al (2024) Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer 23(1):148. https:\/\/doi.org\/10.1186\/s12943-024-02046-3","journal-title":"Mol Cancer"},{"issue":"10","key":"6327_CR6","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrc1994","volume":"6","author":"D Hoeller","year":"2006","unstructured":"Hoeller D, Hecker CM, Dikic I (2006) Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer 6(10):776\u2013788. https:\/\/doi.org\/10.1038\/nrc1994","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"6327_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1258\/ebm.2011.011236","volume":"237","author":"SD Desai","year":"2012","unstructured":"Desai SD, Reed RE, Burks J et al (2012) ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells. Exp Biol Med (Maywood) 237(1):38\u201349. https:\/\/doi.org\/10.1258\/ebm.2011.011236","journal-title":"Exp Biol Med (Maywood)"},{"issue":"28","key":"6327_CR8","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1038\/onc.2009.115","volume":"28","author":"A Kiessling","year":"2009","unstructured":"Kiessling A, Hogrefe C, Erb S et al (2009) Expression, regulation and function of the ISGylation system in prostate cancer. Oncogene 28(28):2606\u20132620. https:\/\/doi.org\/10.1038\/onc.2009.115","journal-title":"Oncogene"},{"issue":"5","key":"6327_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00262-011-1129-9","volume":"61","author":"LM Wood","year":"2012","unstructured":"Wood LM, Pan ZK, Seavey MM et al (2012) The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy. Cancer Immunol Immunother 61(5):689\u2013700. https:\/\/doi.org\/10.1007\/s00262-011-1129-9","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"6327_CR10","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s12272-020-01281-8","volume":"43","author":"J Park","year":"2020","unstructured":"Park J, Cho J, Song EJ (2020) Ubiquitin-proteasome system (UPS) as a target for anticancer treatment. Arch Pharm Res 43(11):1144\u20131161. https:\/\/doi.org\/10.1007\/s12272-020-01281-8","journal-title":"Arch Pharm Res"},{"key":"6327_CR11","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.2741\/1730","volume":"10","author":"CT Dao","year":"2005","unstructured":"Dao CT, Zhang DE (2005) ISG15: a ubiquitin-like enigma. Front Biosci 10:2701\u20132722. https:\/\/doi.org\/10.2741\/1730","journal-title":"Front Biosci"},{"issue":"11","key":"6327_CR12","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1038\/sj.onc.1207393","volume":"23","author":"DT Huang","year":"2004","unstructured":"Huang DT, Walden H, Duda D et al (2004) Ubiquitin-like protein activation. Oncogene 23(11):1958\u20131971. https:\/\/doi.org\/10.1038\/sj.onc.1207393","journal-title":"Oncogene"},{"key":"6327_CR13","doi-asserted-by":"publisher","first-page":"12513","DOI":"10.1038\/ncomms12513","volume":"7","author":"JH Park","year":"2016","unstructured":"Park JH, Yang SW, Park JM et al (2016) Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification. Nat Commun 7:12513. https:\/\/doi.org\/10.1038\/ncomms12513","journal-title":"Nat Commun"},{"issue":"43","key":"6327_CR14","doi-asserted-by":"publisher","first-page":"30963","DOI":"10.1074\/jbc.274.43.30963","volume":"274","author":"TP Moynihan","year":"1999","unstructured":"Moynihan TP, Ardley HC, Nuber U et al (1999) The ubiquitin-conjugating enzymes UbcH7 and UbcH8 interact with RING finger\/IBR motif-containing domains of HHARI and H7-AP1. J Biol Chem 274(43):30963\u201330968. https:\/\/doi.org\/10.1074\/jbc.274.43.30963","journal-title":"J Biol Chem"},{"issue":"24","key":"6327_CR15","doi-asserted-by":"publisher","first-page":"13354","DOI":"10.1073\/pnas.240347797","volume":"97","author":"Y Zhang","year":"2000","unstructured":"Zhang Y, Gao J, Chung KK et al (2000) Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A 97(24):13354\u201313359. https:\/\/doi.org\/10.1073\/pnas.240347797","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6327_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/his.12002","volume":"62","author":"J Choi","year":"2013","unstructured":"Choi J, Jung W, Koo JS (2013) Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer. Histopathology 62(2):275\u2013286. https:\/\/doi.org\/10.1111\/his.12002","journal-title":"Histopathology"},{"issue":"21","key":"6327_CR17","doi-asserted-by":"publisher","first-page":"7836","DOI":"10.3390\/ijms21217836","volume":"21","author":"S Cocco","year":"2020","unstructured":"Cocco S, Leone A, Piezzo M et al (2020) Targeting autophagy in breast cancer. Int J Mol Sci 21(21):7836. https:\/\/doi.org\/10.3390\/ijms21217836","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6327_CR18","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/15548627.2022.2103992","volume":"19","author":"TM Zhang","year":"2023","unstructured":"Zhang TM, Liao L, Yang SY et al (2023) TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression. Autophagy 19(3):805\u2013821. https:\/\/doi.org\/10.1080\/15548627.2022.2103992","journal-title":"Autophagy"},{"issue":"4","key":"6327_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.apsb.2019.10.003","volume":"10","author":"H Xiang","year":"2020","unstructured":"Xiang H, Zhang J, Lin C et al (2020) Targeting autophagy-related protein kinases for potential therapeutic purpose. Acta Pharm Sin B 10(4):569\u2013581. https:\/\/doi.org\/10.1016\/j.apsb.2019.10.003","journal-title":"Acta Pharm Sin B"},{"key":"6327_CR20","doi-asserted-by":"publisher","first-page":"106006","DOI":"10.1016\/j.phrs.2021.106006","volume":"175","author":"YS Abd El-Aziz","year":"2022","unstructured":"Abd El-Aziz YS, Gillson J, Jansson PJ et al (2022) Autophagy: A promising target for triple negative breast cancers. Pharmacol Res 175:106006. https:\/\/doi.org\/10.1016\/j.phrs.2021.106006","journal-title":"Pharmacol Res"},{"issue":"4","key":"6327_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrm1891","volume":"7","author":"A Hergovich","year":"2006","unstructured":"Hergovich A, Stegert MR, Schmitz D et al (2006) NDR kinases regulate essential cell processes from yeast to humans. Nat Rev Mol Cell Biol 7(4):253\u2013264. https:\/\/doi.org\/10.1038\/nrm1891","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"6327_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/genes7050021","volume":"7","author":"A Hergovich","year":"2016","unstructured":"Hergovich A (2016) The roles of NDR protein kinases in hippo signalling. Genes (Basel) 7(5):21. https:\/\/doi.org\/10.3390\/genes7050021","journal-title":"Genes (Basel)"},{"issue":"1","key":"6327_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/2045-3701-3-32","volume":"3","author":"A Hergovich","year":"2013","unstructured":"Hergovich A (2013) Regulation and functions of mammalian LATS\/NDR kinases: looking beyond canonical Hippo signalling. Cell Biosci 3(1):32. https:\/\/doi.org\/10.1186\/2045-3701-3-32","journal-title":"Cell Biosci"},{"issue":"5","key":"6327_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cellsig.2016.02.012","volume":"28","author":"L Hoa","year":"2016","unstructured":"Hoa L, Kulaberoglu Y, Gundogdu R et al (2016) The characterisation of LATS2 kinase regulation in Hippo-YAP signalling. Cell Signal 28(5):488\u2013497. https:\/\/doi.org\/10.1016\/j.cellsig.2016.02.012","journal-title":"Cell Signal"},{"issue":"2","key":"6327_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.bbrc.2006.07.076","volume":"348","author":"T Takeuchi","year":"2006","unstructured":"Takeuchi T, Inoue S, Yokosawa H (2006) Identification and Herc5-mediated ISGylation of novel target proteins. Biochem Biophys Res Commun 348(2):473\u2013477. https:\/\/doi.org\/10.1016\/j.bbrc.2006.07.076","journal-title":"Biochem Biophys Res Commun"},{"issue":"19","key":"6327_CR26","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.cub.2015.08.031","volume":"25","author":"C Joffre","year":"2015","unstructured":"Joffre C, Dupont N, Hoa L et al (2015) The pro-apoptotic STK38 kinase is a new beclin1 partner positively regulating autophagy. Curr Biol 25(19):2479\u20132492. https:\/\/doi.org\/10.1016\/j.cub.2015.08.031","journal-title":"Curr Biol"},{"issue":"12","key":"6327_CR27","first-page":"3788","volume":"8","author":"A Adeyinka","year":"2002","unstructured":"Adeyinka A, Emberley E, Niu Y et al (2002) Analysis of gene expression in ductal carcinoma in situ of the breast. Clin Cancer Res 8(12):3788\u20133795","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6327_CR28","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1073\/pnas.98.3.1176","volume":"98","author":"JB Welsh","year":"2001","unstructured":"Welsh JB, Zarrinkar PP, Sapinoso LM et al (2001) Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci U S A 98(3):1176\u20131181. https:\/\/doi.org\/10.1073\/pnas.98.3.1176","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6327_CR29","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-03-0409","volume":"10","author":"KH Lu","year":"2004","unstructured":"Lu KH, Patterson AP, Wang L et al (2004) Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 10(10):3291\u20133300. https:\/\/doi.org\/10.1158\/1078-0432.CCR-03-0409","journal-title":"Clin Cancer Res"},{"issue":"24","key":"6327_CR30","doi-asserted-by":"publisher","first-page":"13790","DOI":"10.1073\/pnas.191502998","volume":"98","author":"A Bhattacharjee","year":"2001","unstructured":"Bhattacharjee A, Richards WG, Staunton J et al (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 98(24):13790\u201313795. https:\/\/doi.org\/10.1073\/pnas.191502998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6327_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bbapap.2007.07.017","volume":"1784","author":"A Hergovich","year":"2008","unstructured":"Hergovich A, Cornils H, Hemmings BA (2008) Mammalian NDR protein kinases: from regulation to a role in centrosome duplication. Biochim Biophys Acta 1784(1):3\u201315. https:\/\/doi.org\/10.1016\/j.bbapap.2007.07.017","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"6327_CR32","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1158\/1078-0432.CCR-13-2060","volume":"20","author":"S Chittaranjan","year":"2014","unstructured":"Chittaranjan S, Bortnik S, Dragowska WH et al (2014) Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer. Clin Cancer Res 20(12):3159\u20133173. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2060","journal-title":"Clin Cancer Res"},{"issue":"8","key":"6327_CR33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM (2023) Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol 24(8):560\u2013575. https:\/\/doi.org\/10.1038\/s41580-023-00585-z","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"6327_CR34","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.4161\/15548627.2014.981788","volume":"10","author":"S Lefort","year":"2014","unstructured":"Lefort S, Joffre C, Kieffer Y et al (2014) Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers. Autophagy 10(12):2122\u20132142. https:\/\/doi.org\/10.4161\/15548627.2014.981788","journal-title":"Autophagy"},{"key":"6327_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2018.09.007","volume":"438","author":"HG Han","year":"2018","unstructured":"Han HG, Moon HW, Jeon YJ (2018) ISG15 in cancer: Beyond ubiquitin-like protein. Cancer Lett 438:52\u201362. https:\/\/doi.org\/10.1016\/j.canlet.2018.09.007","journal-title":"Cancer Lett"},{"issue":"11","key":"6327_CR36","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/s12276-022-00872-3","volume":"54","author":"JA Kang","year":"2022","unstructured":"Kang JA, Kim YJ, Jeon YJ (2022) The diverse repertoire of ISG15: more intricate than initially thought. Exp Mol Med 54(11):1779\u20131792. https:\/\/doi.org\/10.1038\/s12276-022-00872-3","journal-title":"Exp Mol Med"},{"issue":"3","key":"6327_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1158\/0008-5472.CAN-17-1752","volume":"78","author":"LM Mustachio","year":"2018","unstructured":"Mustachio LM, Lu Y, Kawakami M et al (2018) Evidence for the ISG15-specific deubiquitinase USP18 as an antineoplastic target. Cancer Res 78(3):587\u2013592. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1752","journal-title":"Cancer Res"},{"key":"6327_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2147\/BCTT.S516542","volume":"17","author":"H Jie","year":"2025","unstructured":"Jie H, Ma W, Huang C (2025) Diagnosis, prognosis, and treatment of triple-negative breast cancer: a review. Breast Cancer (Dove Med Press) 17:265\u2013274. https:\/\/doi.org\/10.2147\/BCTT.S516542","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"6327_CR39","doi-asserted-by":"publisher","first-page":"737982","DOI":"10.3389\/fonc.2021.737982","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang L, Sun M, Yang S et al (2021) Intraoperative radiotherapy is not a better alternative to whole breast radiotherapy as a therapeutic option for early-stage breast cancer. Front Oncol 11:737982. https:\/\/doi.org\/10.3389\/fonc.2021.737982","journal-title":"Front Oncol"},{"issue":"3","key":"6327_CR40","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ccell.2025.01.007","volume":"43","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Chen H, Mo H et al (2025) Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer. Cancer Cell 43(3):446\u2013463e7. https:\/\/doi.org\/10.1016\/j.ccell.2025.01.007","journal-title":"Cancer Cell"},{"key":"6327_CR41","doi-asserted-by":"publisher","first-page":"155458","DOI":"10.1016\/j.prp.2024.155458","volume":"260","author":"L Zhang","year":"2024","unstructured":"Zhang L, Gu S, Wang L et al (2024) M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1. Pathol Res Pract 260:155458. https:\/\/doi.org\/10.1016\/j.prp.2024.155458","journal-title":"Pathol Res Pract"},{"issue":"7","key":"6327_CR42","doi-asserted-by":"publisher","first-page":"e13900","DOI":"10.1111\/1440-1681.13900","volume":"51","author":"J Zhang","year":"2024","unstructured":"Zhang J, Ye CX, Chen HT et al (2024) Jianpi-Tiaoqi decoction inhibits tumour proliferation and lung metastasis in tumour-bearing mice with triple-negative breast cancer. Clin Exp Pharmacol Physiol 51(7):e13900. https:\/\/doi.org\/10.1111\/1440-1681.13900","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"6327_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng L, Meng T, Chen L et al (2020) The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther 5(1):11. https:\/\/doi.org\/10.1038\/s41392-020-0107-0","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"6327_CR44","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1038\/s41467-023-41801-w","volume":"14","author":"RN Moro","year":"2023","unstructured":"Moro RN, Biswas U, Kharat SS et al (2023) Interferon restores replication fork stability and cell viability in BRCA-defective cells via ISG15. Nat Commun 14(1):6140. https:\/\/doi.org\/10.1038\/s41467-023-41801-w","journal-title":"Nat Commun"},{"issue":"1","key":"6327_CR45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s12253-018-0478-5","volume":"26","author":"Y Li","year":"2020","unstructured":"Li Y, Bai W, Zhang L (2020) The Overexpression of CD80 and ISG15 Are Associated with the Progression and Metastasis of Breast Cancer by a Meta-Analysis Integrating Three Microarray Datasets. Pathol Oncol Res 26(1):443\u2013452. https:\/\/doi.org\/10.1007\/s12253-018-0478-5","journal-title":"Pathol Oncol Res"},{"issue":"44","key":"6327_CR46","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1038\/s41388-021-02017-8","volume":"40","author":"A Bolado-Carrancio","year":"2021","unstructured":"Bolado-Carrancio A, Lee M, Ewing A et al (2021) ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling. Oncogene 40(44):6235\u20136247. https:\/\/doi.org\/10.1038\/s41388-021-02017-8","journal-title":"Oncogene"},{"issue":"1","key":"6327_CR47","doi-asserted-by":"publisher","first-page":"7970","DOI":"10.1038\/s41467-023-43711-3","volume":"14","author":"I Wallace","year":"2023","unstructured":"Wallace I, Baek K, Prabu JR et al (2023) Insights into the ISG15 transfer cascade by the UBE1L activating enzyme. Nat Commun 14(1):7970. https:\/\/doi.org\/10.1038\/s41467-023-43711-3","journal-title":"Nat Commun"},{"issue":"1","key":"6327_CR48","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1038\/s41467-023-39780-z","volume":"14","author":"M Afsar","year":"2023","unstructured":"Afsar M, Liu G, Jia L et al (2023) Cryo-EM structures of Uba7 reveal the molecular basis for ISG15 activation and E1-E2 thioester transfer. Nat Commun 14(1):4786. https:\/\/doi.org\/10.1038\/s41467-023-39780-z","journal-title":"Nat Commun"},{"issue":"23","key":"6327_CR49","doi-asserted-by":"publisher","first-page":"783","DOI":"10.21037\/atm.2019.11.39","volume":"7","author":"RX Wang","year":"2019","unstructured":"Wang RX, Xu XE, Huang L et al (2019) eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triple-negative breast cancer. Ann Transl Med 7(23):783. https:\/\/doi.org\/10.21037\/atm.2019.11.39","journal-title":"Ann Transl Med"},{"issue":"21","key":"6327_CR50","doi-asserted-by":"publisher","first-page":"35205","DOI":"10.18632\/oncotarget.16925","volume":"8","author":"G Bousquet","year":"2017","unstructured":"Bousquet G, El Bouchtaoui M, Sophie T et al (2017) Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer. Oncotarget 8(21):35205\u201335221. https:\/\/doi.org\/10.18632\/oncotarget.16925","journal-title":"Oncotarget"},{"issue":"9","key":"6327_CR51","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1042\/CS20080508","volume":"116","author":"W Martinet","year":"2009","unstructured":"Martinet W, Agostinis P, Vanhoecke B et al (2009) Autophagy in disease: a double-edged sword with therapeutic potential. Clin Sci (Lond) 116(9):697\u2013712. https:\/\/doi.org\/10.1042\/CS20080508","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"6327_CR52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12967-022-03462-z","volume":"20","author":"S Cocco","year":"2022","unstructured":"Cocco S, Leone A, Roca MS et al (2022) Inhibition of autophagy by chloroquine prevents resistance to PI3K\/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models. J Transl Med 20(1):290. https:\/\/doi.org\/10.1186\/s12967-022-03462-z","journal-title":"J Transl Med"},{"issue":"11","key":"6327_CR53","doi-asserted-by":"publisher","first-page":"e48150","DOI":"10.15252\/embr.201948150","volume":"20","author":"AP Martin","year":"2019","unstructured":"Martin AP, Jacquemyn M, Lipecka J et al (2019) STK38 kinase acts as XPO1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes. EMBO Rep 20(11):e48150. https:\/\/doi.org\/10.15252\/embr.201948150","journal-title":"EMBO Rep"},{"issue":"3","key":"6327_CR54","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/15548627.2015.1135283","volume":"12","author":"C Joffre","year":"2016","unstructured":"Joffre C, Codogno P, Fanto M et al (2016) STK38 at the crossroad between autophagy and apoptosis. Autophagy 12(3):594\u2013595. https:\/\/doi.org\/10.1080\/15548627.2015.1135283","journal-title":"Autophagy"},{"issue":"1","key":"6327_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tcb.2014.09.001","volume":"25","author":"CM Kenific","year":"2015","unstructured":"Kenific CM, Debnath J (2015) Cellular and metabolic functions for autophagy in cancer cells. Trends Cell Biol 25(1):37\u201345. https:\/\/doi.org\/10.1016\/j.tcb.2014.09.001","journal-title":"Trends Cell Biol"},{"issue":"2","key":"6327_CR56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ceb.2009.10.008","volume":"22","author":"CM Kenific","year":"2010","unstructured":"Kenific CM, Thorburn A, Debnath J (2010) Autophagy and metastasis: another double-edged sword. Curr Opin Cell Biol 22(2):241\u2013245. https:\/\/doi.org\/10.1016\/j.ceb.2009.10.008","journal-title":"Curr Opin Cell Biol"},{"key":"6327_CR57","doi-asserted-by":"publisher","first-page":"134120","DOI":"10.1016\/j.ijbiomac.2024.134120","volume":"278","author":"XT Fu","year":"2024","unstructured":"Fu XT, Qie JB, Chen JF et al (2024) Inhibition of SIRT1 relieves hepatocarcinogenesis via alleviating autophagy and inflammation. Int J Biol Macromol 278:134120. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134120","journal-title":"Int J Biol Macromol"},{"issue":"23","key":"6327_CR58","doi-asserted-by":"publisher","first-page":"e70206","DOI":"10.1096\/fj.202401480R","volume":"38","author":"Y Liu","year":"2024","unstructured":"Liu Y, Chen S, Guo K et al (2024) Osteoblast-derived exosomal miR-140-3p targets ACER2 and increases the progression of prostate cancer via the AKT\/mTOR pathway-mediated inhibition of autophagy. FASEB J 38(23):e70206. https:\/\/doi.org\/10.1096\/fj.202401480R","journal-title":"FASEB J"},{"key":"6327_CR59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","volume":"14","author":"Z Su","year":"2015","unstructured":"Su Z, Yang Z, Xu Y et al (2015) Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer 14:48. https:\/\/doi.org\/10.1186\/s12943-015-0321-5","journal-title":"Mol Cancer"},{"key":"6327_CR60","doi-asserted-by":"publisher","unstructured":"Klionsky DJ, Abdel-Aziz AK, Abdelfatah S et al (2021) Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy 17(1):1-382. https:\/\/doi.org\/10.1080\/15548627.2020.1797280","DOI":"10.1080\/15548627.2020.1797280"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06327-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06327-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06327-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:00:43Z","timestamp":1790636443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06327-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6327"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06327-6","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors did not utilize AI for any generative editorial tasks or autonomous content generation.","order":1,"name":"Ethics","label":"AI Use declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors hereby declare that there are no financial interests, personal relationships, or other potential conflicts of interest that could influence the objectivity of this study\u2019s design, implementation, data analysis, or manuscript preparation.","order":2,"name":"Ethics","label":"Financial interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"348"}}